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Human African trypanosomiasis (HAT) is a fatal tropical disease caused by infection with protozoans of the
species Trypanosoma brucei gambiense and T. b. rhodesiense. An oral prodrug, DB289, is a promising new therapy
undergoing phase III clinical trials for early-stage HAT. DB289 is metabolically converted to the active
trypanocidal diamidine DB75 [2,5-bis(4-amidinophenyl)furan]. We previously determined that DB75 inhibits
yeast mitochondrial function (C. A. Lanteri, B. L. Trumpower, R. R. Tidwell, and S. R. Meshnick, Antimicrob.
Agent Chemother. 48:3968–3974, 2004). The purpose of this study was to investigate if DB75 targets the
mitochondrion of T. b. brucei bloodstream forms. DB75 rapidly accumulates within the mitochondria of living
trypanosomes, as indicated by the fluorescent colocalization of DB75 with a mitochondrion-specific dye.
Fluorescence-activated cell sorting analysis of rhodamine 123-stained living trypanosomes shows that DB75
and other trypanocidal diamidines (pentamidine and diminazene) collapse the mitochondrial membrane
potential. DB75 inhibits ATP hydrolysis within T. brucei mitochondria and appears to inhibit the oligomycin-
sensitive F1F0-ATPase and perhaps other ATPases. DB75 is most likely not an inhibitor of electron transport
within trypanosome mitochondria, since DB75 fails to inhibit mitochondrial respiration when glycerol-3-
phosphate is used as the respiratory substrate. However, DB75 inhibits whole-cell respiration (50% inhibitory
concentration, 20 M) at drug concentrations and incubation durations that also result in the dissipation of
the mitochondrial membrane potential. Taken together, these findings suggest that the mitochondrion is a
target of the trypanocidal action of DB75.
New therapies are desperately needed for the treatment of
human African trypanosomiasis (HAT). This reemerging trop-
ical disease afflicts as many as 500,000 people (2, 5). Current
drugs, such as pentamidine, suramin, melarsoprol, eflornithine,
and nifurtimox, are often associated with deleterious side ef-
fects and cannot be administered orally (5, 16, 19, 34).
A promising new therapy, DB289 [2,5-bis-(4-amidinophenyl)-
furan bis-O-methylamidoxime], is undergoing phase III clinical
trials for registration as the first orally administered drug for
early-stage HAT (19). The oral prodrug DB289 is metaboli-
cally converted to the trypanocidal agent DB75 [2,5-bis(4-
amidinophenyl)furan] (6, 50, 51). DB75 is active against
Trypanosoma spp. in vitro (11, 12) and is a structural analogue
of the aromatic diamidine drug pentamidine.
DB75 and pentamidine are antimicrobial diamidine-type
compounds that are active against various fungal and protozoal
infections. However, the mechanism through which diamidine
drugs exert their activity is still not entirely known and contin-
ues to be a focus of extensive research (46). We previously
investigated the mechanisms of action of DB75 and pentami-
dine in yeast cells and found that both drugs appear to disrupt
the mitochondrial function in Saccharomyces cerevisiae by col-
lapsing the mitochondrial membrane potential (m) and in-
hibiting mitochondrial respiration (24). We also showed that
DB75 and pentamidine inhibit oxidative phosphorylation in
isolated rat liver mitochondria (24), which is consistent with
the results attained with pentamidine in a previous study (31).
The purpose of this investigation was to gain insight into the
mechanism of trypanocidal action of DB75. In particular, we
investigated if DB75 acts against Trypanosoma brucei blood-
stream forms (BFs) by targeting the mitochondrion.
MATERIALS AND METHODS
Chemicals. DB75 [2,5-bis(4-amidinophenyl)furan dihydrochloride] was ob-
tained from David Boykin at Georgia State University, Atlanta, and pentamidine
isethionate [1,5-di(4-amidinophenoxy)pentane isethionate] was prepared by
LyphoMed, Inc. (Melrose Park, IL). All other chemicals were of the highest
quality available and were from Sigma-Aldrich (St. Louis, MO), unless otherwise
stated.
Collection and isolation of trypanosomes from infected blood. Male Sprague-
Dawley rats and Swiss-Webster mice (Charles River Laboratories, Cambridge,
MA) were infected by intraperitoneal injection of approximately 2  106 and 5 
105 BFs of Trypanosoma brucei brucei strain 427 cells, respectively. Infected
blood was collected through cardiac puncture at the time of peak parasitemia
(usually day 5 postinfection for rats and day 4 postinfection for mice). The blood
was centrifuged in heparinized tubes at 2,200  g for 10 min at 4°C, and the buffy
coat was removed and diluted 1:3 in phosphate saline glucose buffer, pH 8.0. The
trypanosomes were purified from the blood by the use of DE52 anion-exchange
columns (22).
Fluorescence microscopy. DB75 has an inherent blue fluorescence, and it
excites at 365 nm and emits at 465 nm under UV light. UV fluorescence micros-
copy was used to track the intracellular distribution of DB75 in T. b. brucei S427
cells. Approximately 106 cells were treated with 1.0 M DB75 (10 l of a 1 mM
DB75 solution in sterile distilled water) and were incubated in a T25 flask in a
humidified atmosphere of 5.0% CO2 at 37°C in complete Baltz’s minimal essen-
tial medium (cBMEM), consisting of Eagle’s minimal essential medium with
Earle’s salts supplemented with 0.4 mM L-threonine, 0.1 mM hypoxanthine,
0.016 mM thymidine, 0.08 mM adenosine, 0.2 mM sodium pyruvate, 6 mM
D-glucose, 25 mM HEPES, 25 mM NaHCO3, nonessential amino acids, 0.2 mM
2-mercaptoethanol, 2 mM L-glutamine, and 10% heat-inactivated HyClone fetal
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bovine serum. An aliquot of 1.5 ml was removed after predetermined drug
incubation times and was centrifuged at 1,400  g for 5 min. The resultant pellet
was resuspended, and dried films were prepared for UV fluorescence microscopy
with a Nikon Microphot FXA microscope fitted with a Nikon UV2A filter cube.
Subsequent UV fluorescence microscopy experiments were conducted to deter-
mine if DB75 localizes to T. b. brucei mitochondria. Briefly, 106 cells per ml were
incubated at 37°C in an atmosphere of 5.0% CO2 for 30 min in cBMEM con-
taining 25 nM MitoTracker Red CMXRos (Molecular Probes Inc., Eugene,
OR). The cells were then collected by centrifugation (1,000  g, 10 min) and
resuspended in fresh prewarmed medium lacking dye. These cells were then
treated with 100 M DB75 to determine if the DB75 fluorescence colocalizes
with MitoTracker. To slow down the motility of the trypanosomes so that they
could be viewed under the microscope, 20 l of sample was mixed in 20 l of
3.0% agarose (at 37°C), and the mixture was then spun briefly in a microcentri-
fuge. Next, 20 l of the resultant cell-agar mixture was placed on an ice-cold glass
slide and a coverslip was mounted on the slide. The samples were viewed with a
Nikon Microphot FXA microscope fitted with a Nikon multiband triple-filter
block for 4,6-diamidino-2-phenylindole–fluorescein isothiocyanate–Texas Red.
The intracellular localization of pink fluorescence indicated the distribution of
DB75 and MitoTracker Red together within the T. b. brucei mitochondrion.
Images were captured with Scion Image software.
Preparation of T. b. brucei mitochondrial fraction. The trypanosome mito-
chondrial fraction was prepared by a differential centrifugation protocol (30, 39),
with all steps performed at 0 to 4°C. Isolated trypanosomes were washed once (by
centrifugation at 2,000  g for 10 min at 4°C) in resuspension buffer, which
consisted of 0.12 M sodium phosphate buffer (pH 8.0) containing 86.3 mM NaCl
and 56 mM glucose. The cells were then resuspended in 2.0 ml of buffer and
placed on ice. These packed cells were suspended in an equal volume of glass
beads (diameter, 0.10 to 0.11 mm) and 4.0 ml of homogenization buffer contain-
ing 50 mM HEPES-NaOH buffer (pH 7.2) with 0.27 M sucrose, 1.0 mM EDTA,
and 1.0 mM MgCl2 and 80 l of a freshly prepared concentrated stock solution
of a protease inhibitor cocktail (Roche complete EDTA-free cocktail). The cells
were then mixed vigorously with a Vortex mixer for 2 min; approximately 100%
of the cells were lysed after this treatment. The resultant homogenate was
collected (by centrifugation at 2,000  g for 10 min at 4°C), added to a fresh
15-ml conical tube, and centrifuged again at 900  g for 5 min to remove any
residual cells. The cell extract was collected from this spin, and a crude mito-
chondrial fraction was obtained by centrifugation at 12,000  g for 10 min at 4°C.
The precipitate was resuspended in 5.0 ml of washing buffer, consisting of 10 mM
potassium phosphate buffer (pH 7.5) containing 0.25 M sucrose and 1.0 mM
EDTA, and was washed again by centrifugation at 12,000  g for 10 min. The
resultant pellet was resuspended in a minimal volume (250 to 500 l) of washing
buffer, and the total protein concentration was determined by using a Bio-Rad
protein assay kit with bovine serum albumin (BSA) as the standard. If the
samples were not used on the same day of preparation, they were frozen at
80°C until further use; no observable differences in the results of the oxygen
consumption experiments were obtained when fresh or frozen mitochondrial
preparations were used.
Measurement of oxygen consumption. The oxygen consumption of T. b. brucei
whole cells and mitochondrial preparations was measured at 37°C by using a
Hansatech Instruments Oxytherm system equipped with an oxygen electrode
disc, a borosilicate reaction chamber, and a Teflon-coated magnetic stirring bar.
Parasites isolated from infected rat blood were washed (by centrifugation at
2,000  g, 10 min, 4°C) once in mannitol-based assay buffer (pH 7.4) containing
20 mM glucose as the carbon source and consisting of 220 mM mannitol, 25 mM
HEPES, 2 mM EGTA, and 5 mM MgSO4. The cells were then resuspended, and
the oxygen consumed by 2.0  106 cells per ml was recorded in the presence and
the absence of the test compounds. The respiration of T. b. brucei mitochondrial
preparations was measured by following a protocol adapted from that described
in previous publications (4, 30). Briefly, the mitochondria were suspended to 0.8
mg/ml in mannitol-based assay buffer (pH 7.4) lacking glucose, and a final
concentration of 20 mM L--glycerol phosphate was then added as the respira-
tory substrate. The samples were next loaded into the reaction chamber, and
after a stable reading was achieved (usually after 2 min), various test compounds
were added to the reaction chamber and respiration was recorded for an addi-
tional several minutes. The data were analyzed with Oxyg32 (Hansatech) soft-
ware.
Flow cytometric analysis of m. Fluorescence-activated cell sorting (FACS)
analysis was used to assess changes in the m of T. b. brucei cells, as determined
from the mean fluorescence of cells treated with the fluorescent m-sensitive
dye rhodamine 123 (Rh123) (47). The assay is based upon the principle that the
mitochondrial accumulation and retention of Rh123 are dependent upon the
m across the inner mitochondrial membrane and that the mitochondrial
uptake of Rh123 is directly proportional to the magnitude of m (15, 21, 47).
Trypanosomes isolated from rat blood were resuspended and washed once (by
centrifugation at 2,000  g, 10 min, 4°C) in Tes buffer, which consisted of 118
mM NaCl, 5 mM KCl, 1.2 mM MgSO4, 16 mM Na2HPO4, 1.2 mM KH2PO4, 5
mM NaHCO3, 10 mM glucose, and 30 mM N-[Tris(hydroxymethyl)methyl]-2-
aminoethanesulfonic acid, which was adjusted to pH 7.5 with 1.0 M NaOH, and
which contained fresh 1.0% fatty acid-free BSA (35, 37). The cells were resus-
pended to 108 per ml in Tes buffer and warmed to room temperature. Aliquots
of the cells (107 per ml) were then treated for 10 min with various test com-
pounds, after which time a final concentration of 250 nM Rh123 was added to
each sample for a further 2 min. The cells were diluted 1:10 in buffer immediately
before FACS analysis with a Becton Dickinson FACScan flow cytometer with
fluorescence settings appropriate for the detection of Rh123 emission (	 
 529
nm) and excitation (	 
 507 nm). Summit (version 3.1) software was used to plot
the fluorescence distribution for 20,000 cells as a frequency histogram, and the
mean fluorescence channel was recorded for each sample treatment.
Measurement of ATP consumption within T. b. brucei mitochondrial prepa-
rations. ATP concentrations were measured by using an ATP bioluminescence
assay kit (CLS II; Roche), which uses a method based upon the ATP-dependent
bioluminescence of luciferase. T. b. brucei mitochondrial fractions were diluted
to 100 g of protein in 150 l reaction buffer consisting of 20 mM Tris-HCl (pH
7.4) containing 15 mM KH2PO4, 0.6 M sorbitol, 10 mM MgSO4, and freshly
added 2.5 mg/ml fatty acid-free BSA. The effects of mitochondrial inhibitors and
DB75 on mitochondrial ATP consumption were tested by incubating the samples
for 10 min on ice in the presence of 50 M oligomycin, added as 2.4 l of 2.5
mg/ml solution in ethanol; 50 M carbonylcyanide m-chlorophenylhydrazone
(CCCP), added as 1.5 l of 5 mM solution in ethanol; and 10, 50, or 100 M
DB75, added as 1.5 l of 1 mM, 5 mM, or 10 mM DB75, respectively, in sterile
distilled water. Non-drug-treated samples were also incubated on ice for 10 min,
in order to determine if the drugs were stimulating or inhibiting ATP consump-
tion. To initiate ATPase activity, the samples were then incubated for 30 min at
30°C in the presence of 0.20 mM ATP. Following the incubation, the samples
were processed for the luciferase assay, according to previously reported meth-
ods (1). Briefly, samples were treated with 3.5 l of 60% perchloric acid and were
immediately vortexed. The samples were then incubated on ice for at least 10 min
or until a white precipitate appeared and were spun in an Eppendorf centrifuge
(model 5417C) for 5 min at full speed (20,000  g). From each sample, 120 l
of supernatant was removed and placed in a new tube, to which 23 l of 1.0 N
KOH was added. This was immediately followed by mixing on a Vortex mixer
and incubation on ice for 3 min. The samples were then spun again, and the
resultant supernatant was transferred to a fresh tube and kept on ice. ATP
consumption was assessed in a 100-l total volume consisting of 10 l of sample,
40 l 0.5 M Tris-acetate (pH 7.75), and 50 l of luciferase reagent. ATP
standards in the range of 103 to 1011 M were also tested. Samples were read
with a luminometer in a 96-well white microtiter plate by using a 1-s delay and
an integration time of 1 to 10 s. The data for the blank (no ATP) were subtracted
from the raw data, and the ATP concentrations for each sample were calculated
from a log-log plot of the standard curve with GraphPad Prism software.
RESULTS
Fluorescent localization of DB75 within BFs of T. b. brucei.
The inherent UV fluorescence of DB75 was used to study its
intracellular distribution within BFs of T. b. brucei cells. The
parasites were treated in vitro with 1.0 M DB75, and dried
smears were prepared for microscopy at various time points.
UV fluorescence microscopy showed that DB75 distributes
within the DNA-containing organelles, the nucleus and the
kinetoplast (Fig. 1A). Specifically, the blue fluorescence of
DB75 was observed within a prominent intracellular organelle
located roughly at the midpoint of the cell (Fig. 1A), which is
characteristic of the position of the nucleus (17). In addition,
DB75 fluorescence was observed within a smaller organelle
near the base of the flagellum (Fig. 1A) that corresponded to
the position of the trypanosome organelle containing mito-
chondrial DNA, the kinetoplast (17). The accumulation of
DB75 occurred relatively rapidly, with blue fluorescence being
observed in the nucleus and the kinetoplast within 5 min.
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We were then interested in determining if DB75 also dis-
tributed within the trypanosome mitochondrion, which in the
BF of T. brucei is a thin, elongated structure that runs along the
length of the cell (17). The blue fluorescence of DB75 within
the nucleus and the kinetoplast is very intense (Fig. 1A), mak-
ing it difficult to resolve if DB75 distributes within the much
thinner structure of the mitochondrion. The mitochondrion-
specific dye MitoTracker Red CMXRos (17, 43) was therefore
used to reveal DB75 fluorescence within the mitochondrion.
The thin, tubular structure of the mitochondrion was observed
in living BFs treated with MitoTracker Red alone (Fig. 1B). To
determine if DB75 also enters the mitochondrion, cells pre-
treated with MitoTracker Red were then incubated with 100
M DB75 (Fig. 1C). This higher concentration of DB75 was
optimal for distinguishing the fluorescent distribution of DB75
within the mitochondrion from the more intense staining of
DB75 in other organelles. In these cells, the colocalization of
the blue fluorescence of DB75 with the red-orange fluores-
cence of MitoTracker Red within the mitochondrion was evi-
denced by pink fluorescence (Fig. 1C). DB75 appears to dis-
tribute within the mitochondrion relatively rapidly, with the
fluorescent colocalization of DB75 and MitoTracker Red ob-
served within 5 min (Fig. 1C).
Effect of DB75 on T. b. brucei whole-cell and mitochondrial
respiration. We next investigated the effect of DB75 on the
whole-cell and mitochondrial respiration of T. b. brucei BFs.
DB75 inhibited the oxygen consumption of whole cells in a
mannitol-based buffer containing glucose in a dose-dependent
manner, with a 50% inhibitory concentration of approximately
20 M DB75 (Fig. 2). DB75 at 300 M appeared to completely
inhibit cellular respiration (Fig. 2). The effect of DB75 on the
respiration of isolated mitochondria was then investigated by
using glycerol-3-phosphate (G-3-P) as the substrate. As ex-
pected, 2 mM salicylhydroxamic acid (SHAM), a specific in-
hibitor of the trypanosome mitochondrial -glycerophosphate
oxidase system (9, 33), completely inhibited mitochondrial res-
piration (Fig. 3). In contrast, DB75 at concentrations up to 600
M did not alter G-3-P-dependent oxygen consumption in
isolated trypanosome mitochondria (Fig. 3), whereas concen-
trations of SHAM as low as 10 M were shown to inhibit at
least some oxygen consumption in isolated mitochondria (data
not shown). These results indicate that DB75 is not an inhib-
itor of the SHAM-sensitive mitochondrial alternative oxidase.
DB75 collapses T. b. brucei m. Rh123 is a mitochondrion-
specific dye that accumulates only within energized mitochon-
dria and that is commonly used as a fluorescent probe to
monitor the drug-induced collapse of m in trypanosomes
(15, 47). FACS analysis of the Rh123 fluorescence within T.
congolense cells was previously used to characterize the m of
various trypanosome populations (47). We therefore adapted
this protocol to determine the effect of DB75 on the m of T.
b. brucei BFs in situ. Histograms of total Rh123 fluorescence in
20,000 trypanosomes were generated (Fig. 4A), and the mean
FIG. 1. Cellular distribution of DB75 fluorescence within T. b. bru-
cei BFs. (A) Fluorescent localization of DB75 within the nucleus
(N) and kinetoplast (K) of trypanosomes. Cells were incubated at 37°C
and 5.0% CO2 in cBMEM containing 1.0 M DB75, and after 30 min,
dried films were prepared for UV fluorescence microscopy with a
Nikon Microphot FXA microscope fitted with a Nikon UV2A cube.
(B) The elongated, tubular structure of the mitochondrion (M), typical
of BF parasites, was observed in living cells treated with the mitochon-
drion-specific dye MitoTracker Red. Cells were incubated with 25 nM
MitoTracker Red for 30 min, washed, and suspended in agarose before
UV fluorescence microscopy was performed with living cells with a
Nikon Texas Red filter. (C) Fluorescent colocalization of MitoTracker
Red and DB75 within the trypanosome mitochondrion. Cells were first
treated with 25 nM MitoTracker Red and were next incubated with
100 M DB75 for 5 min, and wet mounts of agarose mixtures were
viewed with a Nikon multiband triple filter block for 4,6-diamidino-
2-phenylindole–fluorescein isothiocyanate–Texas Red. Fluorescent co-
localization, indicated by pink fluorescence, of MitoTracker with DB75
suggests that DB75 enters the mitochondrion. Magnifications, 63.
FIG. 2. DB75 inhibits glucose-dependent cellular respiration in T.
b. brucei BFs. The oxygen consumed by 2  106 cells per ml in man-
nitol-based buffer containing 20 mM glucose was recorded with an
oxygen electrode, and the rates of oxygen consumption were deter-
mined with Oxyg32 software. The percent inhibition of respiration was
determined by comparing the oxygen consumption rates immediately
before and after the addition of DB75. The graph depicts the results
from two independent experiments; error bars associated with the
standard deviations are too small to be represented on the graph.
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fluorescence for each sample served as a relative measure of
m in the presence and the absence of various test com-
pounds.
This method proved to be an effective measure of m
within trypanosomes, as indicated by the ability of mitochon-
drial inhibitors to decrease the mean Rh123 fluorescence (Fig.
4). For example, oligomycin is a specific and potent inhibitor of
the T. brucei mitochondrial F1F0-ATPase that generates the
m within the inner mitochondrial membrane (7, 37). As
expected, treatment of the trypanosomes for 10 min with 4 M
oligomycin resulted in an approximately 50% reduction in
Rh123 fluorescence relative to that for the untreated cells (Fig.
4B). Likewise, 10 M the protonophore CCCP reduced the
Rh123 fluorescence to approximately 51% of that detected in
untreated parasites after a 5-min incubation (Fig. 4B). In ad-
dition, a 10-min incubation with 10 M the ionophore valino-
mycin reduced Rh123 to approximately 70% of that observed
in the no-drug controls (results not shown). In our assay, these
mitochondrial inhibitors behaved as expected, since the drug
FIG. 3. DB75 does not inhibit respiration in T. b. brucei mitochon-
drial preparations. An oxygen electrode was used to measure the
oxygen consumed by mitochondria in mannitol-based buffer containing
20 mM G-3-P as the respiratory substrate in the presence or the
absence of DB75 or SHAM. The arrows indicate the time points at
which 0.8 mg/ml of T. b. brucei mitochondria (arrow 1) and 600 M
DB75 or 2 mM SHAM (arrow 2) were added to the reaction chamber.
FIG. 4. DB75 collapses the mitochondrial membrane potential in T. b. brucei BFs. FACS analysis of the mean Rh123 fluorescence was
conducted as a measure of the drug-induced changes in m. (A) Rh123 fluorescence distribution plotted as frequency histograms. Trypanosomes
(107/ml) were pretreated with 10 M DB75, 4 M oligomycin, or 10 M CCCP for 10 min in Tes buffer supplemented with 1.0% BSA. Next, the
cells were treated with 250 nM Rh123 for a further 2 min, diluted 1:10, and subjected to FACS analysis. The results indicate that the mean Rh123
fluorescence (and, therefore, m) was decreased in drug-treated cells compared to the fluorescence of the untreated cells. The results shown are
representative of at least four independent experiments. (B) FACS analysis results expressed as the percent inhibition of m. Trypanosomes were
pretreated with drug for the times indicated on the graph. The percent inhibition of m was determined by calculating the percent decrease in
the mean Rh123 fluorescence of drug-treated cells relative to the mean fluorescence of the untreated cells. The results shown represent the
averages of at least three independent experiments and indicate that DB75 inhibits m to a similar extent as the mitochondrial inhibitors
oligomycin and CCCP.
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concentrations and incubation times that we observed for m
collapse were identical to those documented in a previous
report that used UV fluorescence microscopy of Rh123 to
monitor drug-mediated m collapse in T. brucei BFs (15).
Furthermore, compounds not expected to affect the mitochon-
drial function in BFs failed to alter the Rh123 fluorescence in
our FACS analysis. Specifically, no change in m was ob-
served in cells treated with the cytochrome oxidase inhibitor
potassium cyanide at 1 mM or the electron transport chain
inhibitor antimycin A at 10 M (results not shown). Taken
together, these results validated our FACS assay for use in the
measurement of drug-induced m collapse in trypanosomes.
Through FACS analysis of Rh123 fluorescence, we discov-
ered that DB75 is a potent inhibitor of m in BFs of T. b.
brucei (Fig. 4). A minimal concentration of 1.0 M DB75 was
required for a detectable decrease in Rh123 fluorescence after
at least 1 min of incubation with drug (results not shown).
DB75 appears to collapse the m relatively quickly, since
only 1 min of incubation with 10 M DB75 was required for
the maximal reduction (approximately 57%) in Rh123 fluores-
cence relative to the incubation time required for the un-
treated cells (Fig. 4B). In addition, DB75 seems to be a more
powerful inhibitor of m than oligomycin and CCCP, since a
1-min incubation with 4 M oligomycin or 10 M CCCP re-
sulted in decreases in Rh123 fluorescence of only 23% and
36%, respectively, compared to the fluorescence of the un-
treated cells (Fig. 4B).
In addition to DB75, other trypanocidal diamidine drugs
were shown to collapse m through our FACS analysis. For
example, 10 min of incubation with 10 M pentamidine or
diminazene aceturate resulted in the dissipation of m (Fig. 5).
DB75 inhibits ATP consumption in mitochondria isolated
from T. b. brucei BFs. We next investigated the mechanism
through which DB75 dissipates the m in T. b. brucei BFs.
One possibility is that DB75 is an inhibitor of the T. brucei
mitochondrial F1F0-ATPase. We found that 50 M oligomycin
inhibited approximately 30% of the mitochondrial ATPase
activity (Fig. 6A). This level of inhibition for oligomycin-
treated T. brucei mitochondrial preparations is similar to that
reported previously (37, 48). Also as expected, treatment with
the protonophore CCCP stimulated ATPase activity in the
trypanosome mitochondrial preparations (Fig. 6A). DB75 at
10 M inhibited approximately 20% of the mitochondrial
ATPase activity, whereas treatment with either 50 or 100 M
DB75 resulted in inhibition of roughly 47% of the ATPase
activity (Fig. 6A). DB75 is therefore a more potent inhibitor of
mitochondrial ATPase than oligomycin when their activities
are compared on a micromolar basis.
We then investigated if DB75 specifically targets the oligo-
mycin-sensitive ATPase. The effect of pretreatment with oli-
gomycin on the ability of DB75 to inhibit ATPase activity was
investigated with isolated T. brucei mitochondria (Fig. 6B).
The results indicate that oligomycin pretreatment did not com-
pletely prevent DB75 from inhibiting mitochondrial ATPase
activity. Thus, perhaps DB75 inhibits other mitochondrial
ATPases in addition to the oligomycin-sensitive F1F0-ATPase.
DISCUSSION
Here we report that the mitochondrion of T. b. brucei BFs
appears to be a cellular target of the trypanocidal diamidine
DB75. The results from this investigation correlate well with
the findings from our previous study (24) in which we used S.
cerevisiae as a model for investigating the antimicrobial action
of DB75. As observed in yeast, DB75 rapidly accumulates
within the mitochondrion of living trypanosomes, as evidenced
by the immediate fluorescent colocalization of DB75 with
MitoTracker Red in cells treated simultaneously with both
drugs (Fig. 1C). DB75 was previously shown to collapse the
m in yeast cells (24), and here we show that DB75 is also a
potent inhibitor of m in trypanosomes (Fig. 4). As occurs in
yeast (24), DB75 inhibits whole-cell respiration (Fig. 2) at
micromolar drug concentrations that also result in the collapse
of m (Fig. 4). We also discovered that DB75 inhibits ATP
hydrolysis in mitochondrial fractions from BF trypanosomes
and appears to be a more potent inhibitor than oligomycin
(Fig. 6). Taken together, the results of this investigation sug-
gest that the killing effect of DB75 in T. brucei BFs involves
m collapse and the inhibition of mitochondrial ATPase
activity.
The functional peculiarities of the mitochondrion in T. bru-
cei BFs make this organelle an attractive candidate as a para-
site-specific drug target. The trypanosome mitochondrion al-
ters the biochemistry of the parasite to facilitate life within the
FIG. 5. Other trypanocidal diamidine drugs, pentamidine isethionate and diminazene aceturate, collapse the mitochondrial membrane poten-
tial in T. b. brucei BFs. Trypanosomes (107/ml) were pretreated with 10 M pentamidine isethionate or diminazene aceturate for 10 min in Tes
buffer supplemented with 1.0% BSA. Next, the cells were treated with 250 nM Rh123 for an additional 2 min, diluted 1:10, and analyzed on the
flow cytometer. The Rh123 fluorescence distribution was plotted as frequency histograms. The results indicate that the mean Rh123 fluorescence
(and, therefore, m) was decreased in drug-treated cells compared to the fluorescence of the untreated controls. The experiment was performed
once.
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distinct environments of the tsetse fly vector and the mamma-
lian host (38, 40, 41). For example, a major functional differ-
ence between the mitochondrion in fly and mammalian infec-
tive forms is the mechanism through which these forms
generate and maintain an energized m (7, 36, 37, 45, 49).
The oligomycin-sensitive F1F0-ATPase of fly-infective forms
(procyclics) functions similarly to the mammalian ATPase,
whereas the ATPase of T. brucei BFs functions differently. In
particular, the establishment of an energized m in procyclics
results in the generation of ATP, since the mitochondrial F1F0-
ATPase (complex 5) couples m generation with the phos-
phorylation of ADP (1, 45). In contrast, maintenance of the
m in BFs requires energy and occurs through ATP hydro-
lysis, mediated by the mitochondrial F1F0-ATPase (7, 37, 45).
Given the functional uniqueness of the mitochondrial F1F0-
ATPase in T. brucei BFs relative to the ATPase in mammalian
host cells, the inhibition of ATP hydrolysis by DB75 is likely to
represent a mechanism of killing that is parasite selective.
Another major distinction of BF trypanosomes relative to
mammalian cells or procyclics is that the mitochondria of BFs
lack cytochromes and respiration is entirely dependent on the
trypanosome alternative oxidase (TAO) system, consisting of
D-glycerol-3-phosphate dehydrogenase and a terminal oxidase
(3, 7, 9, 42). Therefore, inhibitors of TAO activity in vitro are
expected to reduce respiration in BFs. SHAM is a potent TAO
inhibitor that diminishes whole-cell and mitochondrial respi-
ration in BFs; this trend was demonstrated in our oxygen
consumption assays. DB75 inhibited glucose-dependent cellu-
lar respiration in BF trypanosomes (Fig. 2) but did not inhibit
respiration in isolated mitochondria (Fig. 3). These results
could potentially be explained by the fact that mitochondrial
preparations obtained from trypanosomes do not retain an
energized m (15). Therefore, any effects of DB75 upon
mitochondrial respiration resulting from m collapse cannot
be observed in trypanosomal mitochondrial preparations.
However, the abbreviated electron transport chain and the
TAO system of BFs remain intact in such mitochondrial prep-
arations (4, 30). We therefore conclude that DB75 is probably
FIG. 6. Effects of DB75 and mitochondrial inhibitors on ATP consumption by mitochondria isolated from T. b. brucei BFs. (A) Effects of a
10-min incubation with oligomycin, DB75, and CCCP on ATPase activity. DB75 is a more potent inhibitor of mitochondrial ATPase activity than
oligomycin. (B) Effect of a 10-min pretreatment with oligomycin on the ability of DB75 to inhibit ATPase activity. The combination of oligomycin
plus DB75 inhibited the activity to the same degree as DB75 alone did. Mitochondria (100 g protein) were incubated on ice in the absence or
the presence of drugs in 150 l of buffer and were then processed for luciferase-based measurement of ATP consumption (see Materials and
Methods). The ATP concentration within the untreated controls was set as 100% ATPase activity, and the relative activity (%) was determined
for each drug treatment. The results shown are representative of those from three independent experiments, with error bars representing the
standard deviations of duplicate samples.
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not an inhibitor of mitochondrial electron transport or TAO
activity in BF trypanosomes.
How, then, does DB75 inhibit whole-cell respiration in BF
trypanosomes? One possibility is that the DB75-mediated dis-
sipation of m accounts for the observed inhibition of glu-
cose-dependent whole-cell respiration occurring in T. brucei
BFs. This is a reasonable mechanism, because of the similari-
ties in the DB75 M concentrations and the incubation dura-
tions required to observe the drug-induced inhibition of cellu-
lar oxygen uptake (Fig. 2) and m collapse (Fig. 4). The
connection between the DB75-induced dissipation of m and
inhibition of cellular respiration is further supported by the
fact that oligomycin also inhibits glucose-dependent oxygen
uptake (37). It has been suggested that the oligomycin-medi-
ated inhibition of cellular respiration is a result of this drug
indirectly inhibiting glycolysis by limiting the cellular supplies
of ADP and inorganic phosphate required to maintain carbon
flux through pyruvate kinase (29). Like oligomycin, DB75 in-
hibited ATP hydrolysis within T. brucei mitochondrial prepa-
rations (Fig. 6), suggesting that perhaps the DB75-mediated
dissipation of m indirectly inhibits glycolysis through the
depletion of cellular ADP stores. Another explanation for the
DB75-mediated inhibition of cellular respiration is that DB75
has cellular targets in addition to the oligomycin-sensitive
F1F0-ATPase. This explanation is plausible, considering that
DB75 appears to cause a more rapid onset of m collapse
and is a more potent inhibitor of the mitochondrial F1F0-
ATPase than oligomycin.
One probable mechanism through which DB75 collapses
m in BF trypanosomes is via inhibition of the oligomycin-
sensitive mitochondrial F1F0-ATPase. DB75 is a more power-
ful inhibitor of F1F0-ATPase activity than oligomycin when
their activities are compared on a micromolar basis (Fig. 6).
Interestingly, a combination of oligomycin plus DB75 fails to
completely prevent DB75 from inhibiting ATP hydrolysis, per-
haps indicating that DB75 has additional enzymatic targets in
the mitochondrion besides the oligomycin-sensitive F1F0-
ATPase. The possibility that DB75 has other cellular targets in
BFs in addition to the mitochondrial F1F0-ATPase is further
supported by our finding that DB75 collapses the m in yeast
cells (24). Because the m generated in yeast cells is inde-
pendent of F1F0-ATPase activity, it is possible that DB75 deen-
ergizes mitochondria via multiple mechanisms.
Besides the mitochondrion, other cellular components could
potentially be the targets of action of DB75. Indeed, UV flu-
orescence microscopy indicates that DB75 distributes within
other organelles in addition to the mitochondrion (Fig. 1A and
C). DB75 is a known DNA minor groove binder (10, 20, 27)
and therefore is anticipated to interact with the nucleus and
kinetoplast. However, the DNA binding affinity of diphenyl
and aza analogs related to DB75 was recently shown not to be
predictive of trypanocidal potency (25), thereby suggesting that
DNA binding alone does not explain the mechanism through
which diamidines kill trypanosomes.
The collapse of the m by diamidines is a highly plausible
mechanism of trypanocidal activity. We have shown that DB75,
pentamidine, and diminazene potently collapse the m in
trypanosomes (Fig. 5). Pentamidine was expected to disrupt
m, since pentamidine collapses m in Leishmania dono-
vani promastigotes (28, 44) and in mitochondria isolated from
S. cerevisiae (24). However, this is the first known report of the
m-inhibitory action of diminazene aceturate, the active
agent of a drug used to treat trypanosomiasis in livestock and
occasionally to treat early-stage HAT. The diamidine-induced
collapse of m is expected to cause many deleterious down-
stream effects in BFs. The maintenance of an energized mito-
chondrion in BF trypanosomes is absolutely necessary for the
mitochondrial importation of nuclear DNA-encoded proteins
required for the roles that mitochondria play in cellular func-
tions, such as glycolysis, transcription, polyadenylation, and
RNA editing (18, 40). The maintenance of an energized m
is also critical to metabolic functions, such as fatty acid metab-
olism (40) and intracellular calcium homeostasis (32, 45). Fu-
ture studies should investigate the consequences of diamidine-
induced m collapse to definitively determine if these actions
are responsible for BF trypanosome death.
The selective accumulation and concentration of DB75 and
other diamidines within BF trypanosomes is likely to play an
important role in trypanocidal action. DB75 in vivo accumu-
lates and concentrates within trypanosomes to intracellular
concentrations that are 15,000-fold greater than mouse plasma
concentrations (26). A similar concentrative effect was re-
ported in an earlier study with infected mice dosed with pent-
amidine (8), which accumulates within trypanosomes via the
P2 amino purine transporter and two other plasma membrane
transporters (8, 13, 14). We recently determined that DB75 is
rapidly accumulated by trypanosomes primarily through up-
take mediated by the trypanosome-specific P2 amino purine
transporter (23). We can therefore speculate that in vivo treat-
ment with nanomolar concentrations of DB75 should result in
P2 transporter-mediated accumulation of DB75 within BF try-
panosomes to the micromolar levels that we report are re-
quired for the collapse of m.
In summary, we suggest a mechanism of DB75 action in T.
brucei BFs as follows: (i) DB75 is selectively taken up and
accumulated within parasites by the P2 transporter; (ii) DB75
enters the mitochondrion, probably as a result of the fact that
the dicationic nature of DB75 is attracted by the negatively
charged environment of the inner mitochondrial matrix; (iii)
DB75 collapses m via inhibition of the mitochondrial F1F0-
ATPase and possibly other mechanisms; and (iv) the deener-
gization of the mitochondrion results in deleterious down-
stream effects that lead to trypanosome death. This report
paves the way for many interesting avenues of research aimed
at investigating the consequences of the antimitochondrial ef-
fects of DB75 and other clinically relevant diamidines.
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